Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Mar 28;54(4):afaf093.
doi: 10.1093/ageing/afaf093.

What can we learn from 68 000 clinical frailty scale scores? Evaluating the utility of frailty assessment in emergency departments

Affiliations
Multicenter Study

What can we learn from 68 000 clinical frailty scale scores? Evaluating the utility of frailty assessment in emergency departments

Hugh Logan Ellis et al. Age Ageing. .

Abstract

Background: Emergency departments (EDs) in England are under significant strain, with increasing attendances and extended wait times, affecting frail older adults. The clinical frailty scale (CFS) has been implemented as a tool to assess frailty in ED settings, but its reliability and predictive accuracy as a screening tool remain debated.

Objective: To evaluate the use and variability of the CFS in EDs and its association with patient outcomes, including discharge rates, length of stay, readmission and mortality.

Methods: A retrospective cohort study of ED attendances at two London (UK) hospitals from 2017 to 2021. Data included CFS scores, demographics, clinical observations and outcomes. Comparative statistics, logistic regression, Cox proportional hazards models and competing risk regression were applied to examine CFS predictive validity.

Results: In a sample of 123 324 ED visits, CFS scores strongly correlated with adverse outcomes: e.g. for long-term mortality (n = 33 475, events = 8871), each CFS single-point increase was associated with a 25% increase in mortality risk (95% CI 1.23-1.26). CFS scores varied significantly between raters and across visits, median difference two levels (interquartile range 1-3). Intraclass correlation coefficient analysis showed that 33.1% of CFS score differences was attributable to between-patient differences, 15.4% to inter-rater differences, with 51.5% residual variance from non-frailty factors, such as acute illness severity.

Conclusion: The CFS is associated with crucial patient outcomes in the ED. Inter-rater variability and potentially confounding factors can limit its consistency. Automation to enhance CFS score reliability should be explored as a means to support proactive management.

Keywords: clinical frailty scale (CFS); electronic health records (EHRs); emergency department (ED); frailty assessment; older people.

PubMed Disclaimer

Conflict of interest statement

H.L.E. is supported by a Dalhousie Department of Medicine Research Fellowship and KCL Centre for Doctoral Studies PhD stipend. His PhD research focuses on developing data-driven measures of health status including frailty, which could potentially compete with or complement existing frailty measurement tools.

Dr. Rockwood reports grants from Nova Scotia Health Research Fund, during the conduct of the study; personal fees from Ardea Outcomes, the Chinese Medical Association, Wake Forest University Medical School Centre, the University of Nebraska—Omaha, the Australia New Zealand Society of Geriatric Medicine, the Atria Institute, Fraser Health Authority, McMaster University and EpiPharma Inc., outside the submitted work. In addition, Dr. Rockwood has licenced the Clinical Frailty Scale (CFS) to Enanta Pharmaceuticals, Inc., Synairgen Research Ltd, Faraday Pharmaceuticals, Inc., KCR S.A., Icosavax, Inc., BioAge Labs Inc., Biotest AG, Qu Biologics Inc., AstraZeneca UK Ltd., Cellcolabs AB, Pfizer Inc., W.L. Gore Associates Inc., pending to Cook Research Incorporated and Rebibus Therapeutics Inc.; has licenced the Pictorial Fit-Frail Scale (PFFS) to Congenica; and as part of Ardea Outcomes Inc., has a pending patent for Electronic Goal Attainment Scaling. Use of both the CFS and PFFS is free for education, research and non-profit health care with completion of a permission agreement stipulating users will not change, charge for or commercialise the scales. For-profit entities (including pharma) pay a licencing fee, 15% of which is retained by the Dalhousie University Office of Commercialization and Innovation Engagement. The remainder of the licence fees are donated to the Dalhousie Medical Research Foundation and the QEII Health Sciences Centre Research Foundation. In addition to academic and hospital appointments, K.R. is co-founder of Ardea Outcomes (DGI Clinical until 2021), which in the past 3 years has had contracts with pharma and device manufacturers (INmune, Novartis, Takeda) on individualised outcome measurement.

J.T.T. has received research grant funding from National Institutes for Health Research (NIHR), Health Data Research UK (HDR), Innovate UK, Office of Life Sciences, Epilepsy Research Institute, British Heart Foundation, Responsible AI Adoption Unit, OneLondon Secure Data Environment, Kings Health Partners and Engineering & Physical Sciences Research Council (ESPRC). J.T.T. has also received research equipment support from Nvidia, Elastic and Scan Computing. J.T.T. is director and shareholder of CogStack Ltd. None of the funders had any controlling say on the project.

Figures

Figure 1
Figure 1
Kaplan–Meier survival curves illustrating the discharge probability over a 10-day period for various CFS scores. Each curve represents a different CFS score from 1.5 (very fit/fit) to 9 (terminally ill). The graph highlights a clear trend where the discharge probability decreases as frailty increases. Notably, the curves for CFS scores 6, 7, 8 and 9 closely overlap, indicating that beyond a certain level of frailty, further increases in the frailty score do not significantly affect the likelihood of discharge.
Figure 2
Figure 2
Kaplan–Meier survival curves illustrating survival probability over a 90-day period following ED attendance for various CFS scores. Each curve represents a different CFS score from 1.5 (very fit/fit) to 9 (terminally ill). The graph highlights a distinct trend in which the survival probability decreases as frailty increases.
Figure 3
Figure 3
CFS scores over time for the 12 patients of 68 067 with the most frequent ED attendances. Each panel represents an individual patient. The x-axis shows years since their initial admission. The y-axis indicates the CFS score (range 1–9). Data points represent CFS scores recorded at each ED visit. This figure illustrates significant intra-patient variability in CFS scores over relatively short time periods. For example, the third panel in the first row (green dots) shows a patient scoring first 1(‘Very Fit’) and 8 (‘Very severely frail’) within ~3 months, and then surviving for at least 2 years with scores as low as 3 (‘Managing well’). This variability seems at odds with a CFS score that reflects a relatively stable measure of baseline frailty, highlighting potential inconsistencies in CFS assessment.

Similar articles

Cited by

References

    1. Statistics A&E Attendances and Emergency Admissions. https://www.england.nhs.uk/statistics/statistical-work-areas/ae-waiting-....
    1. Jones S, Moulton C, Swift S et al. Association between delays to patient admission from the emergency department and all-cause 30-day mortality. Emerg Med J. 2022;39:168–73. 10.1136/emermed-2021-211572. - DOI - PubMed
    1. Conroy S, Dowsing T. The ability of frailty to predict outcomes in older people attending an acute medical unit. Acute Med. 2013;12:74–6. - PubMed
    1. Kim DH, Rockwood K. Frailty in older adults. N Engl J Med. 2024;391:538–48. 10.1056/NEJMra2301292. - DOI - PMC - PubMed
    1. O’Caoimh R, Sezgin D, O’Donovan MR et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50:96–104. 10.1093/ageing/afaa219. - DOI - PubMed

Publication types